BLOG
Image

Learn

Welcome to Blogs read our latest musings on Small Cap Stocks with a selection of Trade Ideas and Company updates worth noting.

Latest Blogs

Trade Ideas & Company News

Coinsilium: The UK's future MicroStrategy ?

 19 May 2025    7761    Sponge   Crypto 

Coinsilium is one of the first UK listed Blockchain/Web3 Industry pioneers that will also give investors exposure to Bitcoin via it's Forza! wholly owned subsidiary, mimicking that of MicroStrategy, but utilising an innovative approach of yield generation, converting into Bitcoin, which allows you to gain tax free exposure to Bitcoin in your ISA!

Read More

Oxford BioDynamics - On the Cusp of a Major Partnership?

 13 May 2025    5136    Sponge   Pharma 

A revitalised Oxford BioDynamics have been laying the foundations to strike a partnership that would take their market leading precision medical tests out into the global marketplace - a potentially transformational moment for the company.

Read More

5 Reasons to Add Harena Resources to Your Watchlist

 12 May 2025    4614    SmallCapPix   Mining 

Harena is London's latest stock market entrant offering early stage exposure to a hot commodity, namely Rare Earths, particularly the likes of critical magnet metals Neodymium (Nd), Praseodymium (Pr), Dysprosium (Dy) and Terbium (Tb). Here are 5 Reasons to watch it!

Read More

EnergyPathways - An Investors View

 19 Apr 2025    5675    Thom Hudson_   Oil & Gas 

A lot has happened since my last article on EnergyPathways PLC (Ticker: EPP) and if the past few months are anything to go by, it looks like the second half of 2025 will be action-packed.

Read More

Pantheon Resources Trade Idea: Shares bashed, but is this a market overreaction?

 15 Apr 2025    3714    Sponge   Oil & Gas 

Pantheon's shares have taken a battering this week on news that the Megrez-1 TS1 Target was predominantly water bearing. However, the company believe that data gathered, increases confidence in the productivity and hydrocarbon potential of the intervals higher with 5 futher intervals to test.

Read More

In little over a month, Oxford BioDynamics have inked two deals relating to the distribution and sales of its market leading Prostate Cancer PSE test. Does this mark the start of a turnaround for the company?

Read More

Enter your email address to receive content as it's produced.